RxDoctor Payments Data

Julaine Cross, MD

Family Medicine · Cedartown, GANPI 1831134881

Payments from drug & device makers

$1,099in general payments, 2019–2025

Across 64 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$189
  • Novo Nordisk$117
  • Boehringer Ingelheim$112
  • AstraZeneca$101
  • AbbVie$78
  • GSK$71
  • plus $432 from 14 others

What the payments were for

  • Food & beverage$1,099100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,099 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$93,198
Medicare patients
216
Services billed
2,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide103$115,776
OzempicSemaglutide82$103,425
EliquisApixaban117$93,960
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$60,467
TrulicityDulaglutide39$40,434
JardianceEmpagliflozin49$40,122
FarxigaDapagliflozin Propanediol37$31,755
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$13,527
XareltoRivaroxaban21$11,859
MyrbetriqMirabegron26$11,695
Fluticasone-SalmeterolFluticasone Propion/Salmeterol54$10,918
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$10,116
Tresiba Flextouch U-100Insulin Degludec15$8,896
Albuterol Sulfate HfaAlbuterol Sulfate227$7,595
Repatha SureclickEvolocumab14$7,504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$66$156,210142 claims
Novo NordiskOzempic$117$103,42582 claims
PfizerEliquis$70$93,960117 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$71$69,96098 claims
Boehringer IngelheimJardiance$112$40,12249 claims
AstraZenecaFarxiga, Symbicort$101$35,07852 claims
Johnson & JohnsonXarelto$15$11,85921 claims
Astellas Pharma US IncMyrbetriq$62$11,69526 claims
AbbVieSynthroid$78$6,31348 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cedartown

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →